The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
Abstract
When exposed to ionizing radiation (IR), eukaryotic cells activate checkpoint pathways to delay the progression of the cell cycle. Defects in the IR-induced S-phase checkpoint cause 'radioresistant DNA synthesis', a phenomenon that has been identified in cancer-prone patients suffering from ataxia-telangiectasia, a disease caused by mutations in the ATM gene. The Cdc25A phosphatase activates the cyclin-dependent kinase 2 (Cdk2) needed for DNA synthesis, but becomes degraded in response to DNA damage or stalled replication. Here we report a functional link between ATM, the checkpoint signalling kinase Chk2/Cds1 (Chk2) and Cdc25A, and implicate this mechanism in controlling the S-phase checkpoint. We show that IR-induced destruction of Cdc25A requires both ATM and the Chk2-mediated phosphorylation of Cdc25A on serine 123. An IR-induced loss of Cdc25A protein prevents dephosphorylation of Cdk2 and leads to a transient blockade of DNA replication. We also show that tumour-associated Chk2 alleles cannot bind or phosphorylate Cdc25A, and that cells expressing these Chk2 alleles, elevated Cdc25A or a Cdk2 mutant unable to undergo inhibitory phosphorylation (Cdk2AF) fail to inhibit DNA synthesis when irradiated. These results support Chk2 as a candidate tumour suppressor, and identify the ATM-Chk2-Cdc25A-Cdk2 pathway as a genomic integrity checkpoint that prevents radioresistant DNA synthesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both Chk1 and Chk2 regulate the functional associations between BRCA1, BRCA2, and Rad51 proteins in response to DNA damage, and thus promote HR-mediated repair of stalled replication forks [27, 28].”
From NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites (2013) · cites this paper as [28]
In the citing paper
“Moreover, both the ATR-Chk1 and ATM-Chk2 pathways regulate HR-mediated repair of collapsed replication forks [27, 28].”
From NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites (2013) · cites this paper as [28]
In the citing paper
“It has been established that spontaneous HR is promoted by collapsed replication forks that are caused by endogenous DNA SSB [24, 28].”
From NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites (2013) · cites this paper as [28]
Citations
Cites
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,539
Cell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,050
Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase
Matsuoka, S. (1998) · Science · doi:10.1126/science.282.5395.1893 · Cited by 1,322
Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., & Elledge, S. J. (1997) · Science · doi:10.1126/science.277.5331.1497 · Cited by 1,320
The complexity of p53 modulation: emerging patterns from divergent signalsPreprint
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,315
DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2
Hirao, A., Kong, Y., Matsuoka, S., Wakeham, A. C., Ruland, J., Yoshida, H., Liu, D., Elledge, S. J., & Mak, T. W. (2000) · Science · doi:10.1126/science.287.5459.1824 · Cited by 1,311
Stewart, G. S., Maser, R. S., Stankovic, T., Bressan, D. A., Kaplan, M. I., Jaspers, N. G. J., Raams, A., Byrd, P. J., Petrini, J. H. J., & Taylor, A. M. R. (1999) · Cell · doi:10.1016/s0092-8674(00)81547-0 · Cited by 1,060
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M. L., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 899
14-3-3σ is required to prevent mitotic catastrophe after DNA damage
Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Nature · doi:10.1038/44188 · Cited by 895
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,000
A Positive Role for the Ku Complex in DNA Replication Following Strand Break Damage in Mammals
Park, S.-J., Ciccone, S. L. M., Freie, B. W., Kurimasa, A., Chen, D. J., Li, G. C., Clapp, D. W., & Lee, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311054200 · Cited by 36
Cyclin-dependent kinases as targets for cancer therapy
Shah, M. A., & Schwartz, G. K. (2005) · Cancer chemotherapy and biological response modifiers · doi:10.1016/s0921-4410(04)22007-5 · Cited by 35
Li, Y., Zhang, D., Yu, K., Hu, Y., Wu, Q., Qian, F., & Wang, Z. (2018) · Biological Research · doi:10.1186/s40659-018-0159-6 · Cited by 35
Parvovirus-Induced Depletion of Cyclin B1 Prevents Mitotic Entry of Infected Cells
Adeyemi, R. O., & Pintel, D. J. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003891 · Cited by 37
Evaluation of claspin as a proliferation marker in human cancer and normal tissues
Tsimaratou, K., Kletsas, D., Kastrinakis, N. G., Tsantoulis, P. K., Evangelou, K., Sideridou, M., Liontos, M., Poulias, I., Venere, M., Salmas, M., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2095 · Cited by 35
The Many Faces of Redundancy in DNA Replication ControlPreprint
Diffley, J. F. X. (2010) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2010.75.062 · Cited by 38
Long, X., Dai, A., Huang, T., Niu, W., Liu, L., Xu, H., Yin, T., Jiang, T., Sun, S., Lei, P., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c05009 · Cited by 34
Prostate Cancer: A Review of Genetics, Current Biomarkers and Personalised Treatments
Wilson, T. K., & Zishiri, O. T. (2024) · Cancer Reports · doi:10.1002/cnr2.70016 · Cited by 34
zmen, A. Ï. ⁄. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1388 · Cited by 34
Yong-sheng, W., Feng, X., Jin, Y., Wu, Z., Hankey, W., Paisie, C. A., Li, L., Liu, F., Barsky, S. H., Zhang, W., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0213 · Cited by 34
Shimura, T., Toyoshima, M., Adiga, S. K., Kunoh, T., Nagai, H., Shimizu, N., Inoue, M., & Niwa, O. (2006) · Oncogene · doi:10.1038/sj.onc.1209624 · Cited by 34
The accumulation of DNA repair defects is the molecular origin of carcinogenesis
Cha, H., & Yim, H. (2013) · Tumor Biology · doi:10.1007/s13277-013-1038-y · Cited by 34
The relative contribution of CHK1 and CHK2 to Adriamycin-induced checkpoint
HO, C., Siu, W. Y., Chow, J. P. H., Lau, A. W. S., Arooz, T., TONG, H., Ng, I. O., & Poon, R. Y. C. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.10.016 · Cited by 34
Cell cycle stage-specific roles of Rad18 in tolerance and repair of oxidative DNA damage
Yang, Y., Durando, M., Smith-Roe, S. L., Sproul, C., Greenwalt, A. M., Kaufmann, W., Oh, S., Hendrickson, E. A., & Vaziri, C. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1325 · Cited by 33
Oda, T., Gotoh, N., Kasamatsu, T., Handa, H., Saitoh, T., & Sasaki, N. (2023) · Cell Proliferation · doi:10.1111/cpr.13398 · Cited by 33
Tosti, E., Waldbaum, L., Warshaw, G., Gross, E. A., & Ruggieri, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409961200 · Cited by 34
Wang, H., Luo, Y., Lin, Z., Lee, I., Kwon, J., Cui, X., & Kim, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142561 · Cited by 33
14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2
Chen, Y., Li, Z., Dong, Z., Beebe, J., Yang, K., Fu, L., & Zhang, J. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0366 · Cited by 33
miR-21-mediated Radioresistance Occurs via Promoting Repair of DNA Double Strand Breaks
Hu, B., Wang, X., Hu, S., Ying, X., Wang, P., Zhang, X., Wang, J., Wang, H., & Wang, Y. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.772392 · Cited by 34
RetractedHollingworth, R., Horniblow, R. D., Forrest, C., Stewart, G. S., & Grand, R. J. A. (2017) · Journal of Virology · doi:10.1128/jvi.00930-17 · Cited by 34
Neff, D. K., Lee-Dutra, A., Blevitt, J. M., Axe, F. U., Hack, M. D., Buma, J., Rynberg, R., Brunmark, A. B., Karlsson, L., & Breitenbucher, J. G. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.09.098 · Cited by 33
Jeon, Y., Lee, K. Y., Ko, M. J., Lee, Y. S., Kang, S., & Hwang, D. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609116200 · Cited by 34
Laser microbeam-induced DNA damage inhibits cell division in fertilized eggs and early embryos
Wang, Z., Ma, X., Ma, J., Luo, Y., Lin, F., Wang, Z., Fan, H., Schatten, H., & Sun, Q. (2013) · Cell Cycle · doi:10.4161/cc.26327 · Cited by 34
ATM in breast and brain tumors: a comprehensive review
Mehrdad, A. E., & Mehdipour, P. (2018) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2018.0022 · Cited by 34
Nemoto, K., Vogt, A., Oguri, T., & Lazo, J. S. (2003) · The Prostate · doi:10.1002/pros.10292 · Cited by 33
Yadav, B., Kaur, S., Yadav, A., Verma, H., Kar, S., Sahu, B. K., Pati, K. R., Sarkar, B., Dhiman, M., & Mantha, A. K. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23660 · Cited by 34
Liang, X., Reed, E., & Yu, J. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.5.703 · Cited by 32
ATM- and ATR-mediated response to DNA damage induced by a novel camptothecin, ST1968
Zuco, V., Benedetti, V., & Zunino, F. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.12.001 · Cited by 32
Teer, J. K., Machida, Y., Labit, H., Novac, O., Hyrien, O., Marheineke, K., Zannis‐Hadjopoulos, M., & Dutta, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507150200 · Cited by 32
S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11–induced apoptosis of prostate cancer cells
Ray, S., Shyam, S., Fraizer, G. C., & Almasan, A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0414 · Cited by 32
Generation of an indestructible cyclin B1 by caspase-6-dependent cleavage during mitotic catastrophe
Chan, Y. W., Chen, Y., & Poon, R. Y. C. (2008) · Oncogene · doi:10.1038/onc.2008.369 · Cited by 31
Stability of Checkpoint Kinase 2 Is Regulated via Phosphorylation at Serine 456
Kass, E. M., Ahn, J., Tanaka, T., Freed-Pastor, W. A., Keezer, S. M., & Prives, C. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704642200 · Cited by 31
Alkema, N. G., Tomar, T., van der Zee, A. G. J., Everts, M., Meersma, G. J., Hollema, H., de Jong, S., van Vugt, M. A. T. M., & Wisman, G. B. A. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.03.557 · Cited by 31
Zhou, R., Fukui, M., Choi, H. J., & Zhu, B. T. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00268.x · Cited by 31
CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11p110
Choi, H. J., Choi, H.-K., Jung, S. Y., Hyle, J. W., Kim, B., Yoon, K., Cho, E., Youn, H.-D., Lahti, J. M., Qin, J., et al. (2012) · Oncogene · doi:10.1038/onc.2012.535 · Cited by 32
達彦, 鈴., 和夫, 石., Zhao, X., Wu, W., Wang, H., Lu, J., Wu, Q., Chen, X., Fan, W., Chen, H., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq089 · Cited by 31
Madhusoodhanan, R., Natarajan, M., Veeraraghavan, J., Herman, T. S., & Aravindan, N. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.9.8105 · Cited by 31
Joerges, C., Kuntze, I., & Herzinge, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206613 · Cited by 31
Cozma, D., Lukes, L., Rouse, J., Qiu, T. H., Liu, E. T., & Hunter, K. W. (2002) · Genome Research · doi:10.1101/gr.210502 · Cited by 31
PPP2R5A: A multirole protein phosphatase subunit in regulating cancer development
Mao, Z., Liu, C., Lin, X., Sun, B., & Su, C. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.11.024 · Cited by 30
Deubiquitinase USP47-stabilized splicing factor IK regulates the splicing of ATM pre-mRNA
Ka, H. I., Lee, S., Han, S., Jeong, A. L., Park, J. Y., Joo, H. J., Soh, S., Park, D., & Yang, Y. D. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-0268-1 · Cited by 30
He, Y.-Y., Yin, X., Dong, J., Yang, Q., Wu, Y., & Gong, Z. (2021) · Toxins · doi:10.3390/toxins13020167 · Cited by 30
Targeting Non-Oncogene Addiction for Cancer Therapy
Chang, H. R., Jung, E., Cho, S., Jeon, Y.-J., & Kim, Y. (2021) · Biomolecules · doi:10.3390/biom11020129 · Cited by 30
Patro, B. S., Maity, B., & Chattopadhyay, S. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2508 · Cited by 30
An ageing question: Do embryonic stem cells protect their genomes?
Stambrook, P. J. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.007 · Cited by 30
Duch, A., Palou, G., Jónsson, Z. O., Palou, R., Calvo, E., Wohlschlegel, J. A., & Quintana, D. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190843 · Cited by 30
Xu, J., Zhu, W., Xu, W., Cui, X., CHEN, L., Ji, S., Qin, Y., Yao, W., Liu, L., Liu, C., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1901 · Cited by 31
The Nijmegen breakage syndrome gene and its role in genome stability
Iijima, K., Komatsu, K., Matsuura, S., & Tauchi, H. (2004) · Chromosoma · doi:10.1007/s00412-004-0298-0 · Cited by 30
Spotlight on G-Quadruplexes: From Structure and Modulation to Physiological and Pathological Roles
dell’Oca, M. C., Quadri, R., Bernini, G. M., Menin, L., Grasso, L., Rondelli, D., Yazici, O., Sertic, S., Marini, F., Pellicioli, A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063162 · Cited by 35
Hebeisen, M., & Roy, R. (2008) · Development · doi:10.1242/dev.014969 · Cited by 31
Interplay Between the Cell Cycle and Double-Strand Break Response in Mammalian Cells
Beishline, K., & Azizkhan‐Clifford, J. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0888-2_3 · Cited by 31
Nagel, Z. D., Engelward, B. P., Brenner, D. J., Begley, T. J., Sobol, R. W., Bielas, J. H., Stambrook, P. J., Wei, Q., Hu, J. J., Terry, M. B., et al. (2017) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2017.03.007 · Cited by 29
Momčilović, O., Navara, C. S., & Schatten, G. P. (2011) · Results and problems in cell differentiation · doi:10.1007/978-3-642-19065-0_18 · Cited by 30
ATM–p53 pathway causes G2/M arrest, but represses apoptosis in pseudolaric acid B-treated HeLa cells
Yao, G., Qi, M., Ji, X., Fan, S., Xu, L., Hayashi, T., Tashiro, S., Onodera, S., & Ikejima, T. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.05.029 · Cited by 29
UV-induced degradation of securin is mediated by SKP1-CUL1-βTrCP E3 ubiquitin ligase
Limón‐Mortés, M. C., Mora‐Santos, M., Espina, Á. G., Pintor‐Toro, J. A., López-Román, A., Tortolero, M., & Romero, F. (2008) · Journal of Cell Science · doi:10.1242/jcs.020552 · Cited by 29
Obazee, O. M., Archibugi, L., Andriulli, A., Souček, P., Malecka-Panas, E. I., Ivanauskas, A., Johnson, T., Gazouli, M., Pausch, T. M., Lawlor, R. T., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32127 · Cited by 29
Erbb2 Suppresses DNA Damage-Induced Checkpoint Activation and UV-Induced Mouse Skin Tumorigenesis
Madson, J. G., Lynch, D. T., Svoboda, J., Ophardt, R. J., Yanagida, J. K., Putta, S. K., Bowles, A., Trempus, C. S., Tennant, R. W., & Hansen, L. A. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080638 · Cited by 29
Li, J., Lei, C., Chen, B., & Zhu, Q. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.671853 · Cited by 28
Heneberg, P. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5493 · Cited by 29
Garner, K. M., & Eastman, A. R. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-206 · Cited by 29
Thiol‐based redox proteomics in cancer research
Yuan, K., Liu, Y., Chen, H., Zhang, L., Lan, J., Gao, W. Q., Dou, Q., Nice, E. C., & Huang, C. (2014) · PROTEOMICS · doi:10.1002/pmic.201400164 · Cited by 30
Improving the selectivity of cancer treatments by interfering with cell response pathways
Damia, G. L. M., & Broggini, M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.07.020 · Cited by 28
Genetic Modeling of Glioma Formation in Mice
Begemann, M., Fuller, G. N., & Holland, E. C. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00428.x · Cited by 28
Agner, J., Falck, J., Lukas, J., & Bártek, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.035 · Cited by 28
Self-citationDNA damage-induced replication arrest in Xenopus egg extracts
Stokes, M. P., & Michael, W. M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200306006 · Cited by 28
Bertolin, A. P., Canal, B., Yekezare, M., Early, A. E., Zeng, J., Instrell, R., Howell, M., & Diffley, J. F. X. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.06.002 · Cited by 27
Chk2 mediates RITA-induced apoptosis
de Lange, J., Vries, M. V., Teunisse, A. F. A. S., & Jochemsen, A. G. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.182 · Cited by 27
Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers
Ge, Y., Wang, Y., Shao, W., Jin, J., Du, M., Ma, G., Chu, H., Wang, M., & Zhang, Z. (2016) · Scientific Reports · doi:10.1038/srep33542 · Cited by 27
Katoch, A., Nayak, D., Faheem, M. M., Kumar, A., Sahu, P. K., Gupta, A. P., Kumar, L. D., & Goswami, A. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00405-3 · Cited by 27
Defects in G1‐S cell cycle control in head and neck cancer: A review
Michalides, R. J. A. M., van den Brekel, M. W. M., & Balm, F. J. M. (2002) · Head & Neck · doi:10.1002/hed.10109 · Cited by 27
The G2 checkpoint activated by DNA damage does not prevent genome instability in plant cells
Carballo, J. A., Pincheira, J., & de la Torre, C. (2006) · Biological Research · doi:10.4067/s0716-97602006000200015 · Cited by 27
Deregulation of the Cell Cycle by the Epstein–Barr Virus
O’Nions, J., & Allday, M. J. (2004) · Advances in cancer research · doi:10.1016/s0065-230x(04)92006-4 · Cited by 28
The Role of E3 Ligase Pirh2 in Disease
Daks, A. A., Fedorova, O., Parfenyev, S. E., Nevzorov, I. A., Shuvalov, O. Y., & Barlev, N. A. (2022) · Cells · doi:10.3390/cells11091515 · Cited by 19
Centrosomal Chk2 in DNA damage responses and cell cycle progession
Golan, A., Pick, E., Tsvetkov, L. M., Nadler, Y., Kluger, H. M., & Stern, D. F. (2010) · Cell Cycle · doi:10.4161/cc.9.13.12121 · Cited by 28
Nagaprashantha, L. D., Adhikari, R., Singhal, J., Chikara, S., Awasthi, S., Horne, D. A., & Singhal, S. S. (2017) · International Journal of Cancer · doi:10.1002/ijc.31085 · Cited by 26
Song, B., Chen, Y., Liu, Y., Wan, C., Zhang, L., & Zhang, W. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28160 · Cited by 26
Susceptibility Genes Associated with Multiple Primary Cancers
Lu, M., Zhang, X., Chu, Q., Chen, Y., & Zhang, P. (2023) · Cancers · doi:10.3390/cancers15245788 · Cited by 26
Rashid, M. U., Muhammad, N., Faisal, S., Amin, A., & Hamann, U. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-312 · Cited by 26
CHEK2 mutations in primary glioblastomas
Sallinen, S., konen, T., Haapasalo, H. K., & Schleutker, J. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-5953-7 · Cited by 26
Multimodal Control of Cdc25A by Nitrosative Stress
Tomko, R. J., & Lazo, J. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0625 · Cited by 26
Wang, K., Ye, Y., Xu, Z., Zhang, X., Hou, Z., Cui, Y., & Song, Y. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2010.03.006 · Cited by 26
Chuang, L.-C., & Yew, P. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506429200 · Cited by 26
Targeted Therapy in Nonmelanoma Skin Cancers
Spallone, G., Botti, E., & Costanzo, A. (2011) · Cancers · doi:10.3390/cancers3022255 · Cited by 26
Kumar, S., & Huberman, J. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01319-08 · Cited by 26
Lozada, E., Andrysík, Z., Yin, M., Redilla, N., Rice, K., & Stambrook, P. J. (2016) · Oncotarget · doi:10.18632/oncotarget.7966 · Cited by 26
Parsels, L. A., Parsels, J. D., Tai, D. C.-H., Coughlin, D. J., & Maybaum, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3040 · Cited by 27
Wang, X., Guan, J., Hu, B., Weiss, R. S., Iliakis, G. E., & Wang, Y. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh243 · Cited by 26
RetractedNyati, M. K., Feng, F. Y.-C., Maheshwari, D., Varambally, S., Zielske, S. P., Ahsan, A., Chun, P. Y., Arora, V. A., Davis, M. A., Jung, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1935 · Cited by 26
Cyclin-dependent kinases as targets for cancer therapy
Shah, M. A., & Schwartz, G. K. (2003) · Cancer chemotherapy and biological response modifiers · doi:10.1016/s0921-4410(03)21007-3 · Cited by 26
Warren, N. J. H., & Eastman, A. R. (2019) · Oncogene · doi:10.1038/s41388-019-1079-9 · Cited by 27
Yeast as a Tool to Understand the Significance of Human Disease-Associated Gene Variants
Cervelli, T., & Galli, A. (2021) · Genes · doi:10.3390/genes12091303 · Cited by 25
Kostos, L. K., Buteau, J. P., Hofman, M. S., & Azad, A. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359231179309 · Cited by 27
The regulation of CHK2 in human cancer
Craig, A. L., & Hupp, T. R. (2004) · Oncogene · doi:10.1038/sj.onc.1208035 · Cited by 25
Myer, D. L., Robbins, S. B., Yin, M., Boivin, G. P., Liu, Y., Greis, K. D., Bahassi, E. M., & Stambrook, P. J. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.02.006 · Cited by 25
Barkley, L. R., Song, I. Y., Zou, Y., & Vaziri, C. (2009) · Cell Cycle · doi:10.4161/cc.8.10.8535 · Cited by 25
Zhang, L., Jia, G., Li, W.-M., Guo, R., Cui, J., Yang, L., & Lu, Y. (2003) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2003.09.012 · Cited by 25
Roufayel, R., Biggar, K. K., & Storey, K. B. (2011) · Journal of Experimental Zoology Part A Ecological Genetics and Physiology · doi:10.1002/jez.696 · Cited by 25
Badgujar, N. V., Tarapara, B. V., & Shah, F. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220711 · Cited by 25
G1/S CDK is inhibited to restrain mitotic onset when DNA replication is blocked in fission yeast
Zarzov, P., Decottignies, A., Baldacci, G., & Nurse, P. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf346 · Cited by 25
Cui, B., Johnson, S. P., Bullock, N., Ali‐Osman, F., Bigner, D. D., & Friedman, H. S. (2010) · Journal of Biomedical Research · doi:10.1016/s1674-8301(10)60057-7 · Cited by 26
Metadata
- Authors
- Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J.
- Affiliations
- Danish Cancer Society (DK)
- Venue
- Nature
- Published
- 2001-04
- Volume
- 410
- Issue
- 6830
- Pages
- 842-847
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1480741751
- Cited by
- 1,085
- References
- 30
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 22 · 2023: 20 · 2022: 24 · 2021: 29 · 2020: 19 · 2019: 31 · 2018: 24 · 2017: 30 · 2016: 40 · 2015: 30 · 2014: 37 · 2013: 43 · 2012: 55
- FWCI
- 29.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute on Aging
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Keywords
- radioresistant DNA synthesis, ATM, Chk2, CDC25A, CDK2, S-phase checkpoint, ionizing radiation, DNA damage response, tumour suppressor, ataxia telangiectasia, DNA replication inhibition, protein phosphorylation
- MeSH terms
- Alleles, Animals, Cell Cycle, Cell Line, DNA Replication, DNA-Binding Proteins, Humans, Phosphorylation, Protein Kinases, Radiation Tolerance, Radiation, Ionizing, Serine, Transfection, Signal Transduction, S Phase, Protein Serine-Threonine Kinases, Cell Cycle Proteins, cdc25 Phosphatases, Tumor Suppressor Proteins, Mice, Ataxia Telangiectasia Mutated Proteins, Checkpoint Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review